High-density lipoprotein-associated 17β-estradiol fatty acyl ester uptake by Fu5AH hepatoma cells:: Implications of the roles of scavenger receptor class B, type I and the low-density lipoprotein receptor

被引:17
作者
Badeau, Robert M.
Metso, Jari
Tikkanen, Matti J.
Jauhiainen, Matti
机构
[1] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00029, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2007年 / 1771卷 / 10期
关键词
Fu5AH hepatoma cell; BLT-1; apoE;
D O I
10.1016/j.bbalip.2007.08.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
17 beta-Estradiol (E-2) fatty acyl esters naturally incorporate into high-density lipoprotein (HDL). The objective was to elucidate mechanisms involved in HDL-associated E-2 cellular uptake and to determine the intracellular distribution of E2 and its fatty acyl esters (E-2-FAE) after uptake. [3 H]E2 or [3 H] cholesterol was incubated with human serum for 24 h to allow for fatty acyl esterification. Total-HDL containing [3 H]E2-FAE or [3 H]cholesterol esters was isolated by sequential density ultracentrifugation and then incubated with Fu5AH rat hepatoma cells for various time points. Cellular uptake was determined by intracellular radioactivity as a percentage of total radioactivity. Chemical inhibition of scavenger receptor class B, type I and low-density lipoprotein (LDL) receptor competition assays were performed to determine cellular uptake mechanisms. Compared to HDL- [H-3]cholesterol, cellular uptake of HDL-[H-3]E-2 occurred at an initially rapid rate. SR-BI inhibition resulted in a decrease in HDL-E-2 uptake and LDL impaired this uptake in a concentration-dependent manner. Accordingly, pretreatment of cells with BLT-1 combined with LDL addition significantly attenuated HDL-E2 uptake. HDL-E-2-FAE was hydrolyzed into free E2 With the maximum at 24 h. Fu5AH cells facilitate HDL-E2 uptake by at least SR-B1 and LDL receptor pathways and intracellular hydrolysis of E2-FAE into free E2 ensues. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1329 / 1334
页数:6
相关论文
共 26 条
[11]   HDL as a target in the treatment of atherosclerotic cardiovascular disease [J].
Linsel-Nitschke, P ;
Tall, AR .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (03) :193-205
[12]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[13]   HETEROGENEITY OF HUMAN HIGH-DENSITY LIPOPROTEIN - PRESENCE OF LIPOPROTEINS WITH AND WITHOUT APOE AND THEIR ROLES AS SUBSTRATES FOR LECITHIN - CHOLESTEROL ACYLTRANSFERASE REACTION [J].
MARCEL, YL ;
VEZINA, C ;
EMOND, D ;
SUZUE, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2969-2973
[14]   Molecular and cellular basis of cardiovascular gender differences [J].
Mendelsohn, ME ;
Karas, RH .
SCIENCE, 2005, 308 (5728) :1583-1587
[15]   Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI [J].
Nieland, TJF ;
Penman, M ;
Dori, L ;
Krieger, M ;
Kirchhausen, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15422-15427
[16]   PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma [J].
Siggins, S ;
Jauhiainen, M ;
Olkkonen, VM ;
Tenhunen, J ;
Ehnholm, C .
JOURNAL OF LIPID RESEARCH, 2003, 44 (09) :1698-1704
[17]  
SKINNER ER, 1992, LIPOPROTEIN ANAL PRA, P96
[18]  
Soutar AK, 1999, LIPOPROTEINS IN HEALTH AND DISEASE, P303
[19]  
Tikkanen MJ, 1999, LIPOPROTEINS IN HEALTH AND DISEASE, P967
[20]   Lipoprotein-associated estrogens [J].
Tikkanen, MJ ;
Vihma, V ;
Jauhiainen, M ;
Höckerstedt, A ;
Helisten, H ;
Kaamanen, M .
CARDIOVASCULAR RESEARCH, 2002, 56 (02) :184-188